info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)

Global Neurosyphilis Market Is Expected To Reach USD 957.4 Million By 2023

Pune, India, August 9, 2017 /MRFR Press Release/- Market research future has a half cooked research report on global neurosyphilis market. The global neurosyphilis market is growing continuously and expected to grow at a CAGR of 3.9% from 2017 to 2023


Market Highlights


The global neurosyphilis market has been evaluated as a steady market and it is expected to continue growing in the near future. Increasing cases of Neurosyphilis is the major driver for this market.


The market for Neurosyphilis was around USD 732.5 million in 2016 and is expected to reach USD 957.4 million by 2023 which is a projected CAGR of 3.9%.


Taste the market data and market information presented through more than 52 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Neurosyphilis Market Research Report–Global Forecast to 2023.”


Report Details @ https://www.marketresearchfuture.com/reports/neurosyphilis-market-4021


Major players in neurosyphilis market:


There are plenty of large and small market players which operate in this market: Abbott (US), Bayer AG (Germany), Eli Lilly and Company (US), GlaxoSmithKline plc. (UK), Novartis AG (Switzerland), Pfizer Inc. (US), Sanofi (France), and others.


Regional Analysis

:


Considering the global scenario of the neurosyphilis market, there are four main regions, America, Europe, Asia Pacific, and Middle East & Africa.


America is the largest market for neurosyphilis. The Americas mainly include North America and Latin America. North America is holding the largest market share in which US is dominating this market. Due to advanced diagnostic and treatment facilities, funding for research, clinical trials and new drugs and therapy development, and rapid adoption of new therapies, North America region is dominating the global neurosyphilis market. European region is the second important market, especially West European countries are dominating this region. Eastern European countries are also showing significant growth in this market. Asia Pacific market is witnessing rapid growth due to increasing incidence and awareness of neurosyphilis, increasing healthcare expenditure and government initiative to increase awareness as well as to provide affordable healthcare. Talking about the market scenario of Middle East & Africa, this region is expected to grow slower than global average during the forecast period due to various factors such as increasing lack of knowledge, limited access to the required healthcare facilities, availability of required products are restricting the growth of this market etc.


Segmentation:


Global neurosyphilis market has been segmented on the basis of type which comprise asymptomatic neurosyphilis, meningeal neurosyphilis, meningovascular neurosyphilis, general paresis, tabes dorsalis, and others.


On the basis of diagnosis, the market is segmented into physical exam, blood test, spinal tap, imaging tests, and others. Blood test is further subsegmented into Venereal disease research laboratory (VDRL) test, Fluorescent treponemal antibody absorption (FTA-ABS), Rapid plasma reagin (RPR), Treponema pallidum particle agglutination assay (TPPA), and others. Imaging tests is further sub-segmented into Computed Tomography (CT), X-rays, Magnetic resonance imaging (MRI), and others.


On the basis of treatments, the market has been segmented into antibiotic penicillin, antibiotics probenecid, ceftriaxone and others. Antibiotic penicillin is further sub-segmented into Injection and oral.


On the basis of end user, it is segmented into hospital and clinics, medical research centers, academic institutes, and others.


About Market Research Future:


At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.


In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.


Contact


Akash Anand,


Market Research Future


Office No. 528, Amanora Chambers


Magarpatta Road, Hadapsar,


Pune - 411028


Maharashtra, India


+1 646 845 9312


Email: akash.anand@marketresearchfuture.com

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.